SCHEMBL7797214

SCHEMBL7797214

CCCCCCCCCCCCSC(CO)CCCCCCCCCCCC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.50
EPHX1 P07099 1/20 0.44
CYP2D6 P10635 2/20 0.42
SPHK1 Q9NYA1 1/20 0.42
GMNN O75496 1/20 0.42
POLB P06746 1/20 0.42
THPO P40225 1/20 0.42
MTOR P42345 1/20 0.42
BLM P54132 1/20 0.42
KDM4E B2RXH2 1/20 0.42
TP53 P04637 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
MAPT P10636 1/20 0.42
CETP P11597 1/20 0.42
HTT P42858 1/20 0.42
UBE2N P61088 1/20 0.42
FDPS P14324 4/20 0.41
SMPD1 P17405 3/20 0.37
ALDH1A1 P00352 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14902963 0.87 EPHX1 (0.45) LMNAEPHX1SPHK1FDPSSMPD1
SCHEMBL23130425 0.87 EPHX1 (0.45) LMNAEPHX1SPHK1FDPSSMPD1
SCHEMBL9798469 0.87 EPHX1 (0.45) LMNAEPHX1CYP2D6SPHK1GMNN
SCHEMBL23129956 0.87 EPHX1 (0.45) LMNAEPHX1SPHK1FDPSSMPD1
SCHEMBL18837643 0.85 EPHX1 (0.46) LMNAEPHX1CYP2D6SPHK1GMNN
SCHEMBL18837634 0.85 EPHX1 (0.46) LMNAEPHX1CYP2D6SPHK1GMNN
SCHEMBL18837636 0.85 EPHX1 (0.46) LMNAEPHX1CYP2D6SPHK1GMNN
SCHEMBL18837599 0.85 EPHX1 (0.46) LMNAEPHX1CYP2D6SPHK1GMNN
SCHEMBL26351182 0.84 EPHX1 (0.42) LMNAEPHX1MAPTFDPSSMPD1
SCHEMBL18699066 0.83 EPHX1 (0.42) LMNAEPHX1SPHK1FDPSSMPD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6177469-B1 ANTIUTOR AGENTS; AUTOIMMUNE DISEASES HEIDELBERG PHARMA HOLDING GMBH (DE) 2001-01-23 US claimed
EP-0854708-B1 LIPID ALCOHOLS AS NEW IMMUNOSUPPRESSIVE AND ANTIVIRAL DRUGS HEIDELBERG PHARMA HOLDING GMBH (DE) 2001-12-12 EP disclosed
US-6177469-B1 ANTIUTOR AGENTS; AUTOIMMUNE DISEASES HEIDELBERG PHARMA HOLDING GMBH (DE) 2001-01-23 US disclosed
EP-0854708-A1 LIPID ALCOHOLS AS NEW IMMUNOSUPPRESSIVE AND ANTIVIRAL DRUGS Roche Diagnostics GmbH (DE) 1998-07-29 EP disclosed
WO-1997014410-A1 LIPID ALCOHOLS AS NEW IMMUNOSUPPRESSIVE AND ANTIVIRAL DRUGS BOEHRINGER MANNHEIM GMBH (DE) 1997-04-24 WO disclosed
EP-0506704-B1 USE OF ALKYL PHOSPHOLIPIDS AS ANTIVIRAL DRUGS, AS WELL AS NEW COMPOUNDS BOEHRINGER MANNHEIM GMBH (DE) 1994-03-23 EP disclosed
EP-0506704-A1 USE OF ALKYL PHOSPHOLIPIDS AS ANTIVIRAL DRUGS, AS WELL AS NEW COMPOUNDS. BOEHRINGER MANNHEIM GMBH (DE) 1992-10-07 EP disclosed
WO-1991009602-A2 USE OF ALKYL PHOSPHOLIPIDS AS ANTIVIRAL DRUGS, AS WELL AS NEW COMPOUNDS BOEHRINGER MANNHEIM GMBH (DE) 1991-07-11 WO disclosed